- Home
- OCUP vs PRTS Comparison
OCUP vs PRTS Comparison
Compare OCUP & PRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCUP
- PRTS
- Stock Information
- Founded
- OCUP 2018
- PRTS 1995
- Country
- OCUP United States
- PRTS United States
- Employees
- OCUP N/A
- PRTS N/A
- Industry
- OCUP Biotechnology: Pharmaceutical Preparations
- PRTS Auto & Home Supply Stores
- Sector
- OCUP Health Care
- PRTS Consumer Discretionary
- Exchange
- OCUP Nasdaq
- PRTS Nasdaq
- Market Cap
- OCUP 53.1M
- PRTS 48.4M
- IPO Year
- OCUP N/A
- PRTS 2007
- Fundamental
- Price
- OCUP $1.32
- PRTS $0.90
- Analyst Decision
- OCUP Strong Buy
- PRTS Buy
- Analyst Count
- OCUP 3
- PRTS 4
- Target Price
- OCUP $18.67
- PRTS $2.33
- AVG Volume (30 Days)
- OCUP 86.6K
- PRTS 393.0K
- Earning Date
- OCUP 11-11-2024
- PRTS 10-28-2024
- Dividend Yield
- OCUP N/A
- PRTS N/A
- EPS Growth
- OCUP N/A
- PRTS N/A
- EPS
- OCUP N/A
- PRTS N/A
- Revenue
- OCUP $16,449,000.00
- PRTS $633,818,000.00
- Revenue This Year
- OCUP N/A
- PRTS N/A
- Revenue Next Year
- OCUP $258.69
- PRTS $2.32
- P/E Ratio
- OCUP N/A
- PRTS N/A
- Revenue Growth
- OCUP N/A
- PRTS N/A
- 52 Week Low
- OCUP $1.15
- PRTS $0.72
- 52 Week High
- OCUP $3.53
- PRTS $4.17
- Technical
- Relative Strength Index (RSI)
- OCUP 48.70
- PRTS 52.75
- Support Level
- OCUP $1.25
- PRTS $0.87
- Resistance Level
- OCUP $1.35
- PRTS $0.95
- Average True Range (ATR)
- OCUP 0.08
- PRTS 0.04
- MACD
- OCUP 0.01
- PRTS 0.00
- Stochastic Oscillator
- OCUP 29.17
- PRTS 59.00
About OCUP Ocuphire Pharma Inc.
Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting the front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.